MedPath

Evaluation of a gamified augmented reality app as part of a multiple baseline study in people with phobias

Not Applicable
Recruiting
Conditions
F40
Phobic anxiety disorders
Registration Number
DRKS00033470
Lead Sponsor
Sozialstiftung Bamberg, Klinik für Psychiatrie und Psychotherapie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Presence of a phobic disorder

Exclusion Criteria

Presence of schizophrenia or delusional disorder
treatment with electroconvulsive therapy during or one month prior to the study
severely impaired vision

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary endpoint is the subjectively experienced level of anxiety (recorded at all five measurement times) on a scale from 0 to 100).
Secondary Outcome Measures
NameTimeMethod
The following standardized anxiety questionnaires will be administered before the first and after the fifth appointment:<br>Body Sensations Questionnaire (BSQ)<br>Anxiety Sensitivity Index (ASI-3)<br>Agoraphobia Cognition Scale (ACS).<br>In addition, the current depressive symptoms are to be recorded using the following self rating and externalratimg scales:<br>Beck Depression Inventory II (BDI-II)<br>Montgomery-Åsberg Depression Rating Scale (MADRS)
© Copyright 2025. All Rights Reserved by MedPath